Weekly Tech+Bio Highlights #62: Virtual Biology, Open Co-Folding, and a World-Model Lab Agent
Lilly expands AI drug discovery via Insilico & XtalPi deals, Neuralink's Rival raises $200M, AI healthcare funding at $10.7B in 2025
Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.
If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button: